| Identification | Back Directory | [Name]
Brovincamine Fumarte | [CAS]
84964-12-5 | [Synonyms]
Sabromin
Zabromin
BV 26-723
Brovincamin
Sabromin (new)
Hydrogen fumarate
Brovincamine Fumarte
BROVINCAMINE FUMARATE
11-Bromovincamine fumarate
Brovincamine hydrogen fumarate
Eburnamenine-14-carboxylic acid, 11-bromo-14,15-dihydro-14-hydroxy-, methyl ester, (3α,14β,16α)-, (E)-2-butenedioate (1:1) (salt)
Eburnamenine-14-carboxylic acid, 11-bromo-14,15-dihydro-14-hydroxy-, methyl ester, (3α,14β,16α)-, (2E)-2-butenedioate (1:1) (salt) | [Molecular Formula]
C21H25BrN2O3.C4H4O4 | [MOL File]
84964-12-5.mol | [Molecular Weight]
549.415 |
| Hazard Information | Back Directory | [Description]
Brovincamine Fumarate is a derivative of vincamine which selectively increases cranial and coronary blood flow. It is reported to be useful in the treatment of multi-infarct dementia. | [Originator]
Sandoz (Switzerland) | [Definition]
ChEBI: Brovincamine fumarate is an alkaloid. | [Brand name]
SABROMIN |
|
| Company Name: |
MOLEKULA Ltd.
|
| Tel: |
+44 (0) 1747 831066 |
| Website: |
www.molekula.co.uk |
|